Professor, Pediatrics, University of Cincinnati College of Medicine
Pediatric Hematology & Oncology
Dr. Maryam Fouladi, MD
|
|
Give Review
Maryam Fouladi, MD practices Pediatric Hematology & Oncology. She received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Maryam Fouladi is also a published doctor. She has 69 publication published. The most recent publication is: Inadvertent instillation of Minims eye drops in an ophthalmic casualty department.
Publications
- A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade Gliomas and diffuse intrinsic pontine Gliomas.
- Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
- A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors.
- Molecular biology of pediatric Brain tumors and impact on novel therapies.
- Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas.
- Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.
- Pediatric tectal plate Gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae.
- A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric Brain tumor consortium study.
- A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase 1 Consor...
- Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.
- Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children'...
- Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central Nervous system tumors: a PBTC study.
- 18F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium.
- Erratum to: Prognostic significance of telomere maintenance mechanisms in pediatric high-grade Gliomas.
- A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report†.
- A phase I trial of MK-2206 in children with refractory Malignancies: A children's oncology group study.
- Prognostic significance of telomere maintenance mechanisms in pediatric high-grade Gliomas.
- A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112).
- Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): A Pediatric Brain Tumor Cons...
- A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric Brain tumor consortium study.
- A Pediatric Phase 1 Trial of Vorinostat and Temozolomide in Relapsed or Refractory Primary Brain or Spinal Cord Tumors: A Children's Oncology Group Phase 1 Consortium ...
- Histological predictors of outcome in ependymoma are dependent on anatomic site within the central Nervous system.
- Pharmacotherapeutic management of pediatric Gliomas : current and upcoming strategies.
- A prognostic gene expression signature in infratentorial ependymoma.
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study.
- Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor.
- Medulloblastoma with melanotic differentiation: case report and review of the literature.
- Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine Gliomas.
- Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study.
- Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).
- Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.
- Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with Medulloblastoma.
- Carboplatin-based primary chemotherapy for infants and young children with CNS tumors.
- Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.
- Amifostine protects against cisplatin-induced ototoxicity in children with average-risk Medulloblastoma.
- Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse Brainstem glioma.
- Diffusion tensor imaging of Brainstem tumors: axonal degeneration of motor and sensory tracts.
- High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant Brain tumors.
- Endocrine outcomes for children with embryonal Brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem...
- A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, Medulloblastoma/primitive neuroectoder...
- Phase I study of everolimus in pediatric patients with refractory solid tumors.
- Survival and late mortality in long-term survivors of pediatric CNS tumors.
- Phase II study of oxaliplatin in children with recurrent or refractory Medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid...
- Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed Medulloblastoma (St Jude Medulloblastom...
- Chromosome 17 abnormalities in pediatric neuroblastic tumor with abundant neuropil and true rosettes.
- Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children''s Oncology Group report.
- Intratumoral hemorrhage among children with newly diagnosed, diffuse Brainstem glioma.
- Determination of lapatinib (GW572016) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS).
- Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
- Polar spongioblastoma of the spinal cord: a case report.
- Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood Cancer models in vivo.
- End-of-life care preferences of pediatric patients with Cancer.
- Ependymoma: new therapeutic approaches including radiation and chemotherapy.
- Intellectual and functional outcome of children 3 years old or younger who have CNS Malignancies.
- Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
- Role of temozolomide after radiotherapy for newly diagnosed diffuse Brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
- White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with Medulloblastoma or primitive neuroectodermal...
- Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature.
- Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk Medulloblastoma and supratentorial primitive neuroectodermal tumor.
- Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central Nervous system tumors.
- Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients.
- Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study...
- Training subspecialty nurses in developing countries: methods, outcome, and cost.
- Survival and functional outcome of children with hypothalamic/chiasmatic tumors.
- Relation between Irofulven (MGI-114) Systemic exposure and tumor response in human solid tumor xenografts.
- Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy.
- Inadvertent instillation of Minims eye drops in an ophthalmic casualty department.
- Erratum: Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Schools
University Of Toronto Faculty Of Medicine
Hospital Sick Children
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Lung Cancer
- Osteosarcoma
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
University of Toronto Faculty of Medicine
Hospital
-
Cincinnati Children's Hospital Medical Center
Helpful Reviews
Similar Doctors
|
|
Pooja Khandelwal, MB
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trent R. Hummel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Mizukawa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah E. Fitzgerald, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Mangino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen C. Burns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonata Jodele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Perentesis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Punam Malik, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Sharat Chandra, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph Salloum, MD
This Doctor is OpenDoctor Recommended.
|